secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0001493152-24-004506
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem Biosciences second amendment to merger with Aditxt extends loan deadline to Feb 29, proxy filing to Apr 1
--------------------------------------------------------------------------------

- Second Amendment to Merger Agreement dated January 30, 2024 extends Parent loan deadline from Jan 31 to Feb 29, 2024.
- Company's termination right for failure to receive loan also extended to Feb 29, 2024.
- Joint proxy statement filing deadline moved from Jan 31 to April 1, 2024.
- No other material changes; all other terms of Merger Agreement remain in full force and effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224004506/0001493152-24-004506-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224004506/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-004506

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer